Coronary angioplasty for early postinfarction unstable angina

Circulation
|December 1, 1986
PubMed

Insights

Coronary angioplasty effectively treated recurrent unstable angina post-myocardial infarction, with an 89% initial success rate and an 11% myocardial infarction rate at six months. This procedure offers a viable option for patients refractory to medical management.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Recurrent unstable angina after myocardial infarction (MI) poses a significant clinical challenge.
  • Pharmacologic management is often insufficient for these high-risk patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of coronary angioplasty in patients experiencing recurrent unstable angina within 30 days post-MI.
  • To assess the impact of timing (early vs. late post-MI) on angioplasty outcomes.

Main Methods:

  • Coronary angioplasty was performed in 53 patients with recurrent unstable angina after MI.
  • Patients were stratified based on treatment timing: 2-14 days (n=35) and 15-30 days (n=18) post-MI.
  • Outcomes including procedural success, complications (MI), and angina recurrence at 6 months were analyzed.

Main Results:

  • Initial success rate for coronary angioplasty was 89% (47/53).
  • The procedure-related myocardial infarction rate was 8% (4/53).
  • At 6 months, 26% experienced angina recurrence, with a total MI rate of 11%.

Conclusions:

  • Coronary angioplasty is a safe and effective treatment for recurrent unstable angina post-MI.
  • While early angioplasty (2-14 days) showed a trend towards lower success, the difference was not statistically significant compared to later treatment (15-30 days).
  • The procedure demonstrates acceptable complication rates and provides a valuable therapeutic option for selected patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...